# Topical Cetirizine in Androgenetic Alopecia in Females

> **NCT04481412** · PHASE2,PHASE3 · COMPLETED · sponsor: **Cairo University** · enrollment: 66 (actual)

## Conditions studied

- Androgenetic Alopecia

## Interventions

- **DRUG:** Topical cetirizine
- **DRUG:** Placebo
- **DRUG:** Topical minoxidil

## Key facts

- **NCT ID:** NCT04481412
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-25
- **Primary completion:** 2021-11-30
- **Final completion:** 2021-11-30
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04481412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04481412, "Topical Cetirizine in Androgenetic Alopecia in Females". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04481412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*